These observations, together with the observed decrease in RPE mRNA expression of IDH2 (Figure 9J), the limiting enzyme in the reductive carboxylation pathway essential for RPE metabolism, suggest decreased mitochondrial oxidative function in the RPE in AMD patients. Here, IDH2 is linked to age-related macular degeneration.